Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Natco Pharma soars after Mylan settles Ozempic patent dispute

Natco Pharma rose 3.39% to Rs 1400.60 after the company announced a settlement in the U.S. patent litigation for generic Ozempic.

By: business-standard.com

Oct 07 2024
0
0 Views

Natco Pharma soars after Mylan settles Ozempic patent dispute

Natco Pharma soars after Mylan settles Ozempic patent dispute

Related

HDFC AMC jumps 17% in seven days; crosses 1-trillion MCap

Dabur India fixes record date for interim dividend

INR rises 4 paise to settle at 84 against US dollar

Sai Industries reports standalone net loss of Rs 0.01 crore in the September 2024 quarter

Tips Music standalone net profit rises 21.46% in the September 2024 quarter

TVS Credit Services consolidated net profit rises 19.40% in the September 2024 quarter

Himadri Speciality Chemical consolidated net profit rises 34.50% in the September 2024 quarter

JM Financial Services Pvt standalone net profit rises 163.02% in the September 2024 quarter

Kritika Wires standalone net profit rises 20.20% in the September 2024 quarter

Nifty October futures trade at premium

Auto shares slide

Consumer goods stocks edge lower

HDFC AMC jumps 17% in seven days; crosses 1-trillion MCap